Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review
| Autor: | Graeme F. Mason, Eric A. Woodcock, Ansel T. Hillmer, Kelly P. Cosgrove |
|---|---|
| Rok vydání: | 2019 |
| Předmět: | |
| Zdroj: | Mol Neuropsychiatry |
| ISSN: | 2673-298X 2673-3005 |
| DOI: | 10.1159/000499621 |
| Popis: | There is tremendous interest in the role of the neuroimmune system and inflammatory processes in substance use disorders (SUDs). Imaging biomarkers of the neuroimmune system in vivo provide a vital translational bridge between preclinical and clinical research. Herein, we examine two imaging techniques that measure putative indices of the neuroimmune system and review their application among SUDs. Positron emission tomography (PET) imaging of 18 kDa translocator protein availability is a marker associated with microglia. Proton magnetic resonance spectroscopy quantification of myo-inositol levels is a putative glial marker found in astrocytes. Neuroinflammatory responses are initiated and maintained by microglia and astrocytes, and thus represent important imaging markers. The goal of this review is to summarize neuroimaging findings from the substance use literature that report data using these markers and discuss possible mechanisms of action. The extant literature indicates abused substances exert diverse and complex neuroimmune effects. Moreover, drug effects may change across addiction stages, i.e. the neuroimmune effects of acute drug administration may differ from chronic use. This burgeoning field has considerable potential to improve our understanding and treatment of SUDs. Future research is needed to determine how targeting the neuroimmune system may improve treatment outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|